{"id":"W2574014792","doi":"10.1016/j.leukres.2017.01.023","title":"Characterization of treatment and outcomes in a population-based cohort of patients with chronic lymphocytic leukemia referred for cytogenetic testing in British Columbia, Canada","year":2017,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"GlaxoSmithKline (Canada); St. Paul's Hospital; Canada's Michael Smith Genome Sciences Centre; Royal Columbian Hospital; University of British Columbia; Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Fludarabine; Medicine; Rituximab; Hazard ratio; Internal medicine; Chemoimmunotherapy; Population; Chronic lymphocytic leukemia; Confidence interval; Regimen; Proportional hazards model; Oncology; Cohort; Alemtuzumab; Vincristine; Surgery; Cyclophosphamide; Chemotherapy; Leukemia; Transplantation; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005014753,0.0004201,0.0006541656,0.001724749,0.003160097,0.001968309,0.001930597,0.0008747798,0.002123918],"category_scores_gemma":[0.002757969,0.0005207158,0.0005332446,0.005215574,0.001085871,0.0004980296,0.001120195,0.001317171,0.0003585535],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01986865,"about_ca_system_score_gemma":0.01922444,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9833777,"about_ca_topic_score_gemma":0.9864063,"domain_scores_codex":[0.9984478,0.0001447627,0.0001116873,0.0003165154,0.000356156,0.0006231559],"domain_scores_gemma":[0.9972491,0.0001995909,0.0004630984,0.0001357026,0.001154447,0.000798148],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00005709334,0.00002128947,0.9978113,0.000006064854,0.00003261679,0.0001029308,0.0002853396,0.00006151012,0.0001596326,0.00004108645,0.0004849632,0.0009362333],"study_design_scores_gemma":[0.000007107167,0.00001796196,0.9978523,0.00001400273,0.00002176092,0.0001360146,0.001343404,0.0001655508,0.00003076746,0.00002410306,0.0003780781,0.000008963179],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952692,0.0004001442,0.00008928726,0.0003105238,0.0000104024,0.00002373921,0.002428595,0.000008663386,0.001459356],"genre_scores_gemma":[0.9978624,0.0002386496,0.00005739899,0.0001323928,0.000005460129,0.00001256107,0.001233378,0.000006575617,0.0004511912],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01986865,"threshold_uncertainty_score":0.1441579,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03724798008251208,"score_gpt":0.3164581650059118,"score_spread":0.2792101849233997,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}